Fig. 1From: Single-dose botulinum toxin type a compared with repeated-dose for treatment of trigeminal neuralgia: a pilot studyMonthly VAS scores of TN patients. Patients in the single- and repeated-dose groups were followed for 6 consecutive months after the first BTX-A injection. At each follow-up, the VAS scores of the 2 groups were comparableBack to article page